American Society for Radiation Oncology (ASTRO) | sciencenewsnet.in

Breaking News

MSU researchers receive $4M NIH grant to study dementia risks

E-Cigarette Residue Exposure in Utero Shows Lasting Effects on Immune Response

Scientists discover ‘entirely unanticipated’ role of protein netrin1 in spinal cord development

What happens if the Department of Education disappears? Expert warns how it could threaten quality, student mobility and more.

Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers

NASA’s Hubble Sees Aftermath of Galaxy’s Scrape with Milky Way

MSU expert: Diseases threaten deer populations

Woods Hole Oceanographic Institution and Brazilian State of Pará sign Memorandum of Understanding in advance of COP30

New Study Highlights Urgent Need for Targeted Suicide Prevention and Mental Health Support for Sexual and Gender Diverse Youth

ETRI, Demonstration of 8-Photon Qubit Chip for Quantum Computation

14 Nov, 2024

Winners of the ASTRO-Sumitomo Pharma-Pfizer Alliance new combination therapy challenge announced

September 27, 2023 sarah JonasAnnouncement

The American Society for Radiation Oncology (ASTRO) today announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.